News Archive Featured in the Media JeffNEWS In the Community

WHO
Patients, families, healthcare professionals, and anyone else interested in learning the most current information about Hepatitis C – a virus that affects the largest vital organ in the human body and more patients in the U.S. than HIV/AIDS – including leading edge treatments that are on the horizon.  Last year, over 300 people attended.

WHAT
The Hepatology and Liver Transplantation Program of Thomas Jefferson University Hospital and the American Liver Foundation Delaware Valley Chapter present Hepatitis C: State of the Art for You!, a comprehensive, open-to-the-public program featuring top experts from across the region who will speak and answer questions.  This event, the largest public education liver program in the country, will also include breakout sessions that will enable attendees to talk about specific topics of interest ranging from the latest clinical trials to how to prepare for liver transplantation. 

WHEN
Saturday, April 21, 8:15 a.m. – 1:00 p.m.    

WHERE
Jefferson Medical College Building, 1025 Walnut Street, Foerderer Hall, 2^nd Floor

COST & PARKING
$10 per person; $5 for each addition member of a group.  Financial assistance available.  Complimentary breakfast and lunch served. Free parking at Central garage, located on 10th St., between Sansom and Walnut Sts., directly across from the Jefferson Emergency Department.

DETAILS
Did you know that 80 percent of those infected with the Hepatitis C virus (HCV) show no signs or symptoms?  Were you aware that HCV is the leading indication for liver transplantation in the United States?  Or, that new, more tolerable, leading-edge treatments will emerge within the next decade?

Join event chair Victor Navarro, M.D., medical director of Hepatology and Liver Transplantation at Thomas Jefferson University Hospital, and other experts from Albert Einstein Medical Center, Temple University Hospital, Frankford-Torresdale Hospital, the Hospital of the University of Pennsylvania, and Abington Memorial Hospital to learn about: the human liver; how HCV is acquired and who is at risk; standard HCV treatments and new ones on the horizon; how to know if your liver is failing; how to cope with treatment side effects; and HCV is treated after transplantation.  Breakout sessions will focus on: clinical trials; paying for treatment; protecting your liver with lifestyle adjustments and alternative treatments; preparing for transplantation; and taking care of yourself after transplantation.

Call the American Liver Foundation Delaware Valley Chapter at 610-668-0152 to register or for more information.